As of 11:30 AM on the 1st, JW Pharmaceutical's stock price is 35,000 KRW, up 1.01% from the previous day, with a trading volume of 537,190 shares, which is 39.53% of the 5-day average trading volume. On May 29, JW Pharmaceutical became a market issue with the news of the 'Actemra COVID-19 treatment clinical trial' showing strength.
In addition to JW Pharmaceutical, posts from investors are also surging regarding NAVER (035420), Samchully Bicycle (024950), and Koryo Industry (002140).

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

